People - Pharmaceutical Technology

Latest Issue
PharmTech

Latest Issue
PharmTech Europe

People

PTSM: Pharmaceutical Technology Sourcing and Management
Volume 3, Issue 2

People on the move in February 2007.

Greenwich, CT (Feb. 20)Aptuit, Inc. ( http://www.aptuit.com/) announced a series of promotions and shifting of responsibility in its senior management team. These changes include: Frank J. Wright becomes vice-chairman, responsible for external value creation and global integration activities and also has been nominated to the company's board of managers. Scott L. Houlton becomes chief operating officer, with responsibility for scientific operations, business process Improvement, human resources, clinical operations, and capital development. Michael J. Butler, president, scientific operations, will take responsibility for Aptuit's technology and innovation investment activities, including research and development. And Robert G. Burford, managing director, has assumed additional responsibility as chairman of the management committee of Aptuit Consulting.

InformexUSA, San Francisco (Feb. 14)—Halocarbon Products Corporation (River Edge, NJ, http://www.halocarbon.com/) named Mary Ellen Rubinstein marketing manager with responsibility for three product lines: inhalation anesthetics; fluorochemicals; and oils, greases, and waxes. Halocarbon is a producer of specialty fluorochemicals.

ADVERTISEMENT

blog comments powered by Disqus
LCGC E-mail Newsletters

Subscribe: Click to learn more about the newsletter
| Weekly
| Monthly
|Monthly
| Weekly

Survey
FDASIA was signed into law two years ago. Where has the most progress been made in implementation?
Reducing drug shortages
Breakthrough designations
Protecting the supply chain
Expedited reviews of drug submissions
More stakeholder involvement
Reducing drug shortages
38%
Breakthrough designations
13%
Protecting the supply chain
38%
Expedited reviews of drug submissions
13%
More stakeholder involvement
0%
View Results
Jim Miller Outsourcing Outlook Jim Miller Health Systems Raise the Bar on Reimbursing New Drugs
Cynthia Challener, PhD Ingredients Insider Cynthia ChallenerThe Mainstreaming of Continuous Flow API Synthesis
Jill Wechsler Regulatory Watch Jill Wechsler Industry Seeks Clearer Standards for Track and Trace
Siegfried Schmitt Ask the Expert Siegfried SchmittData Integrity
NIH Translational Research Partnership Yields Promising Therapy
Clusters set to benefit from improved funding climate but IP rights are even more critical
Supplier Audit Program Marks Progress
FDA, Drug Companies Struggle with Compassionate Use Requests
USP Faces New Challenges
Source: PTSM: Pharmaceutical Technology Sourcing and Management,
Click here